TY - JOUR
T1 - Superoxide inhibits neuronal nitric oxide synthase influences on afferent arterioles in spontaneously hypertensive rats
AU - Ichihara, Atsuhiro
AU - Hayashi, Matsuhiko
AU - Hirota, Nobuhisa
AU - Saruta, Takao
PY - 2001
Y1 - 2001
N2 - This study was designed to determine the influence of increased superoxide anion in neuronal nitric oxide synthase (nNOS)-dependent regulation of afferent arterioles in spontaneously hypertensive rats (SHR). Afferent arteriolar diameters of male Wistar-Kyoto rats (WKY) and SHR were assessed in vitro with the blood-perfused juxtamedullary nephron technique and averaged 21.6±1.6 (n=6) and 18.8±1.2 (n=7) μm, respectively. The superoxide dismutase mimetic Tempol (1, 10, and 100 μmol/L) did not influence afferent arterioles of WKY but significantly increased afferent arteriolar diameters of SHR by 20.6±5.5%, 25.2±5.4%, and 23.3±4.9%, respectively. In WKY (n=6), the nNOS inhibitor S-methyl-L-thiocitrulline (L-SMTC: 10 μmol/L) and the NOS inhibitor Nω-nitro-L-arginine (L-NNA; 100 μmol/L) significantly decreased afferent arteriolar diameters (19.6±1.6 μm) by 11.9±3.1% and 21.0±3.9%, respectively. In SHR (n=7), L-SMTC did not influence afferent arteriolar diameters (21.0±1.5 μm), but L-NNA exerted an afferent arteriolar constriction (14.8±3.2%) that was similar to the response observed in WKY. Experiments were also performed in the presence of 100μmol/L Tempol. In afferent arterioles of WKY (n=6). Tempol treatment did not modulate the basal diameters (21.5±1.2 μm) or the constrictor response to L-SMTC (10.6±2.1%) or L-NNA (19.3±3.3%). In SHR (n=8), Tempol significantly increased afferent arteriolar diameters by 22.5±4.3% and enhanced afferent arteriolar constrictor responses to L-SMTC (18.4±2.7%) and L-NNA (31.9±2.6%). However, the nitric oxide donor S-nitroso-N-acetylpenicillamine (10μmol/L), which similarly increased afferent arteriolar diameters (17.2±2.3%, n=6), did not affect afferent arteriolar responses to L-SMTC (1.5±2.7%) or L-NNA (18.6±2.3%). These suggest that superoxide anion inhibits the control of afferent arteriolar diameters by nNOS in SHR.
AB - This study was designed to determine the influence of increased superoxide anion in neuronal nitric oxide synthase (nNOS)-dependent regulation of afferent arterioles in spontaneously hypertensive rats (SHR). Afferent arteriolar diameters of male Wistar-Kyoto rats (WKY) and SHR were assessed in vitro with the blood-perfused juxtamedullary nephron technique and averaged 21.6±1.6 (n=6) and 18.8±1.2 (n=7) μm, respectively. The superoxide dismutase mimetic Tempol (1, 10, and 100 μmol/L) did not influence afferent arterioles of WKY but significantly increased afferent arteriolar diameters of SHR by 20.6±5.5%, 25.2±5.4%, and 23.3±4.9%, respectively. In WKY (n=6), the nNOS inhibitor S-methyl-L-thiocitrulline (L-SMTC: 10 μmol/L) and the NOS inhibitor Nω-nitro-L-arginine (L-NNA; 100 μmol/L) significantly decreased afferent arteriolar diameters (19.6±1.6 μm) by 11.9±3.1% and 21.0±3.9%, respectively. In SHR (n=7), L-SMTC did not influence afferent arteriolar diameters (21.0±1.5 μm), but L-NNA exerted an afferent arteriolar constriction (14.8±3.2%) that was similar to the response observed in WKY. Experiments were also performed in the presence of 100μmol/L Tempol. In afferent arterioles of WKY (n=6). Tempol treatment did not modulate the basal diameters (21.5±1.2 μm) or the constrictor response to L-SMTC (10.6±2.1%) or L-NNA (19.3±3.3%). In SHR (n=8), Tempol significantly increased afferent arteriolar diameters by 22.5±4.3% and enhanced afferent arteriolar constrictor responses to L-SMTC (18.4±2.7%) and L-NNA (31.9±2.6%). However, the nitric oxide donor S-nitroso-N-acetylpenicillamine (10μmol/L), which similarly increased afferent arteriolar diameters (17.2±2.3%, n=6), did not affect afferent arteriolar responses to L-SMTC (1.5±2.7%) or L-NNA (18.6±2.3%). These suggest that superoxide anion inhibits the control of afferent arteriolar diameters by nNOS in SHR.
KW - Arterioles
KW - Kidney
KW - Nitric oxide synthase
KW - Rats
KW - Spontaneously hypertensive
KW - Tempol
UR - http://www.scopus.com/inward/record.url?scp=0035098301&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0035098301&partnerID=8YFLogxK
U2 - 10.1161/01.hyp.37.2.630
DO - 10.1161/01.hyp.37.2.630
M3 - Article
C2 - 11230347
AN - SCOPUS:0035098301
SN - 0194-911X
VL - 37
SP - 630
EP - 634
JO - Hypertension
JF - Hypertension
IS - 2 II
ER -